Lenalidomide (Revlimid®) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

Lenalidomide (Revlimid®) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis

Published:2009-11 Issue:1 Volume:220 Page:191-197
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Neymotin Arie,Petri Susanne,Calingasan Noel Y.,Wille Elizabeth,Schafer Peter,Stewart Charles,Hensley Kenneth,Beal M. Flint,Kiaei Mahmoud

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference21 articles.

1. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis;Almer;Ann. Neurol.,2001

2. The evolution of thalidomide and its IMiD derivatives as anticancer agents;Bartlett;Nat. Rev. Cancer,2004

3. Onset and progression in inherited ALS determined by motor neurons and microglia;Boillee;Science,2006

4. Unraveling the mechanisms involved in motor neuron degeneration in ALS;Bruijn;Annu. Rev. Neurosci.,2004

5. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha;Corral;J. Immunol.,1999

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies;Medicinal Research Reviews;2024-03-26

2. Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review;International Journal of Molecular Sciences;2024-02-01

3. Reduction of inflammation and mitochondrial degeneration in mutant SOD1 mice through inhibition of voltage-gated potassium channel Kv1.3;Frontiers in Molecular Neuroscience;2024-01-16

4. Aluminum induces neuroinflammation via P2X7 receptor activating NLRP3 inflammasome pathway;Ecotoxicology and Environmental Safety;2023-01

5. Computational Strategies to Identify New Drug Candidates against Neuroinflammation;Current Medicinal Chemistry;2022-08